Genetic and environmental factors influencing the placental growth factor (PGF) variation in two populations

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Sorice, Rossella ^a   Ruggiero, Daniela ^a   Nutile, Teresa ^a   Aversano, Mario ^a   Husemoen, Lotte ^b   Linneberg, Allan ^b   Bourgain, Catherine ^c   Leutenegger, Anne Louise ^c   Ciullo, Marina ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b Research Centre for Prevention and Health   (Denmark)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL GROWTH FACTOR;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; HEREDITY; HUMAN; ITALY; MALE; PGF GENE; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

DENMARK; FEMALE; GENETICS, POPULATION; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY PROTEINS; QUALITY CONTROL;

EID: 84865165925     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042537     Document Type: Article

References (44)

1. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG, ((1991)) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 88:: 9267--9271.
2. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, et al. ((2003)) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9:: 936--943.
3. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, et al. ((2001)) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:: 575--583.
4. Karumanchi SA, Lindheimer MD, ((2008)) Advances in the understanding of eclampsia. Curr Hypertens Rep 10:: 305--312.
5. Khaliq A, Foreman D, Ahmed A, Weich H, Gregor Z, et al. ((1998)) Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest 78:: 109--116.
6. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, et al. ((1994)) Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:: 4233--4237.
7. Donnini S, Machein MR, Plate KH, Weich HA, ((1999)) Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. J Pathol 189:: 66--71.
8. Adini A, Kornaga T, Firoozbakht F, Benjamin LE, ((2002)) Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 62:: 2749--2752.
9. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, et al. ((2002)) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8:: 831--840.
10. Odorisio T, Cianfarani F, Failla CM, Zambruno G, ((2006)) The placenta growth factor in skin angiogenesis. J Dermatol Sci 41:: 11--19.
11. Rakic JM, Lambert V, Devy L, Luttun A, Carmeliet P, et al. ((2003)) Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 44:: 3186--3193.
12. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, et al. ((2006)) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. Faseb J 20:: 1495--1497.
13. Autiero M, Luttun A, Tjwa M, Carmeliet P, ((2003)) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1:: 1356--1370.
14. Fischer C, Mazzone M, Jonckx B, Carmeliet P, ((2008)) FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8:: 942--956.
15. Ho MC, Chen CN, Lee H, Hsieh FJ, Shun CT, et al. ((2007)) Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma. Cancer Lett 250:: 237--249.
16. Cassidy A, Chiuve SE, Manson JE, Rexrode KM, Girman CJ, et al. ((2009)) Potential role for plasma placental growth factor in predicting coronary heart disease risk in women. Arterioscler Thromb Vasc Biol 29:: 134--139.
17. Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, et al. ((2006)) Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 47:: 307--311.
18. Yoo SA, Yoon HJ, Kim HS, Chae CB, De Falco S, et al. ((2009)) Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum 60:: 345--354.
19. Colonna V, Nutile T, Ferrucci RR, Fardella G, Aversano M, et al. ((2009)) Comparing population structure as inferred from genealogical versus genetic information. Eur J Hum Genet 17:: 1635--1641.
20. Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 268:: 296--308.
21. O'Connell JR, Weeks DE, ((1998)) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:: 259--266.
22. Almasy L, Blangero J, ((1998)) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:: 1198--1211.
23. Nyholt DR, ((2004)) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:: 765--769.
24. Li J, Ji L, ((2005)) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95:: 221--227.
25. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, et al. ((2008)) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:: 161--169.
26. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, et al. ((2011)) Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123:: 731--738.
27. Siervo M, Ruggiero D, Sorice R, Nutile T, Aversano M, et al. ((2010)) Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J Intern Med 268:: 338--347.
28. Suzumori N, Sugiura-Ogasawara M, Katano K, Suzumori K, ((2003)) Women with endometriosis have increased levels of placental growth factor in the peritoneal fluid compared with women with cystadenomas. Hum Reprod 18:: 2595--2598.
29. Hildebrandt VA, Babischkin JS, Koos RD, Pepe GJ, Albrecht ED, ((2001)) Developmental regulation of vascular endothelial growth/permeability factor messenger ribonucleic acid levels in and vascularization of the villous placenta during baboon pregnancy. Endocrinology 142:: 2050--2057.
30. Ejaz E, Shimada A, Woong LC, ((2005)) Toxicological screening for the effects of short-term exposure of sidestream cigarette smoke on angiogenesis. Drug Chem Toxicol 28:: 447--465.
31. Ivnitski-Steele I, Walker MK, ((2005)) Inhibition of neovascularization by environmental agents. Cardiovasc Toxicol 5:: 215--226.
32. Dasgupta P, Chellappan SP, ((2006)) Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5:: 2324--2328.
33. Conklin BS, Zhao W, Zhong DS, Chen C, ((2002)) Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 160:: 413--418.
34. Debette S, Visvikis-Siest S, Chen MH, Ndiaye NC, Song C, et al. ((2011)) Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. Circ Res 109:: 554--563.
35. Ogge G, Romero R, Kusanovic JP, Chaiworapongsa T, Dong Z, et al. ((2010)) Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice. J Matern Fetal Neonatal Med 23:: 820--827.
36. Traglia M, Sala C, Masciullo C, Cverhova V, Lori F, et al. ((2009)) Heritability and demographic analyses in the large isolated population of Val Borbera suggest advantages in mapping complex traits genes. PLoS One 4:: e7554.
37. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, et al. ((2009)) Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325:: 1246--1250.
38. Nica AC, Parts L, Glass D, Nisbet J, Barrett A, et al. ((2011)) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 7:: e1002003.
39. Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, et al. ((2012)) Patterns of cis regulatory variation in diverse human populations. PLoS Genet 8:: e1002639.
40. Ishiji T, Lace MJ, Parkkinen S, Anderson RD, Haugen TH, et al. ((1992)) Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. Embo J 11:: 2271--2281.
41. Kaneko KJ, DePamphilis ML, ((1998)) Regulation of gene expression at the beginning of mammalian development and the TEAD family of transcription factors. Dev Genet 22:: 43--55.
42. Jacquemin P, Martial JA, Davidson I, ((1997)) Human TEF-5 is preferentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer. J Biol Chem 272:: 12928--12937.
43. Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, et al. ((2004)) Prognostic value of placental growth factor in patients with acute chest pain. JAMA 291:: 435--441.
44. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, et al. ((2005)) Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51:: 810--824.